FDA Inspection 1083980 — Ardelyx, Inc.
The FDA completed an inspection of Ardelyx, Inc. on March 12, 2019 in Fremont, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 12, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Fremont, CA (United States)
Additional Details
Sponsor, Contract Research Organization